|
NCAPD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.275200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.613580E-01 |
| Normal-vs-Stage2 |
5.475200E-01 |
| Normal-vs-Stage3 |
1.183220E-01 |
| Normal-vs-Stage4 |
9.431200E-01 |
| Stage1-vs-Stage2 |
7.125000E-01 |
| Stage1-vs-Stage3 |
4.475400E-01 |
| Stage1-vs-Stage4 |
2.943600E-01 |
| Stage2-vs-Stage3 |
4.232800E-01 |
| Stage2-vs-Stage4 |
6.311200E-01 |
| Stage3-vs-Stage4 |
1.511820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.685640E-01 |
| Normal-vs-AfricanAmerican |
6.066800E-01 |
| Normal-vs-Asian |
2.629400E-01 |
| Caucasian-vs-AfricanAmerican |
5.762000E-01 |
| Caucasian-vs-Asian |
9.882400E-02 |
| AfricanAmerican-vs-Asian |
2.185000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.600430E-01 |
| Normal-vs-Female |
5.179000E-01 |
| Male-vs-Female |
2.252200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.993400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.355400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.214600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.271990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.056600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.751600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.451900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.376400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.326000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.176200E-01 |
| Normal-vs-Grade 2 |
1.447190E-01 |
| Normal-vs-Grade 3 |
8.816400E-02 |
| Normal-vs-Grade 4 |
8.806600E-01 |
| Grade 1-vs-Grade 2 |
1.287440E-01 |
| Grade 1-vs-Grade 3 |
1.288780E-01 |
| Grade 1-vs-Grade 4 |
5.628000E-01 |
| Grade 2-vs-Grade 3 |
5.183600E-01 |
| Grade 2-vs-Grade 4 |
2.353000E-01 |
| Grade 3-vs-Grade 4 |
1.394050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.504100E-02 |
| Normal-vs-ccB subtype |
9.419800E-01 |
| ccA subtype-vs-ccB subtype |
2.051700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.734800E-01 |
| Normal-vs-N1 |
4.067800E-01 |
| N0-vs-N1 |
1.505770E-01 |
|
|
